In recent years, the field of interventional oncology has emerged as a critical component in the comprehensive treatment of cancer. Defined as a subspecialty of interventional radiology, interventional oncology (IO) utilizes minimally invasive procedures to diagnose, treat, and manage cancerous tumors. The global interventional oncology market encompasses a variety of products and techniques, each playing... Continue Reading →
The Evolution of Patient-Derived Xenograft Models: From Bench to Bedside
The Patient-Derived Xenograft (PDX) model has emerged as a cornerstone in preclinical research, offering a promising bridge between laboratory findings and clinical outcomes. By implanting human tumor tissues into immunodeficient mice, PDX models maintain the histological architecture and genetic makeup of the original patient's tumor, thus providing a more accurate representation of human cancer biology... Continue Reading →
Technological Advancements Driving the Diagnostic Imaging Services Market
The diagnostic imaging services market has witnessed substantial growth over the past decade, driven by advancements in imaging technology, increasing prevalence of chronic diseases, and a rising geriatric population. This market encompasses a wide range of procedures including Magnetic Resonance Imaging (MRI), Ultrasound, Computed Tomography (CT), X-Ray, Nuclear Imaging, and Mammography. Each of these procedures... Continue Reading →
North America Dominates Thriving Tissue Engineering Market, Europe Follows Closely
The global tissue engineering market is projected to expand from $4.4 billion in 2023 to $8.9 billion by 2028, representing a strong CAGR of 15.3%. Key growth drivers include the rising need for advanced regenerative medicines to treat chronic and degenerative diseases, as well as increasing incidence of traumatic injuries from accidents. Download a PDF... Continue Reading →
Minimally Invasive Cancer Therapies Drive Growth in the Interventional Oncology Market
The global interventional oncology market is projected to experience robust growth in the coming years, driven by several key factors. Valued at $1.9 billion in 2020, this market is expected to reach $2.9 billion by 2026, growing at an impressive compound annual growth rate (CAGR) of 6.8%. Download a PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=203687164 The Rise of... Continue Reading →
Unveiling the Radiotherapy Market: Trends, Drivers, and Opportunities for Growth
The global radiotherapy market is witnessing significant growth, driven by the alarming rise in cancer cases worldwide and the development of advanced radiotherapy treatments. According to a recent report by MarketsandMarkets, the market's revenue was estimated to be $6.9 billion in 2023 and is projected to reach $8.8 billion by 2028, exhibiting a compound annual... Continue Reading →
Precision Oncology and Beyond: The Impact of Companion Diagnostics
According to a new report by MarketsandMarkets™ – Companion Diagnostics Market in terms of revenue was estimated to be worth $7.5 billion in 2024 and is poised to reach $13.6 billion by 2029, growing at a CAGR of 12.6% from 2024 to 2029. The global companion diagnostics market is poised for significant growth in the near future,... Continue Reading →